Trial Profile
Dose-escalation study of intranasal scopolamine gel
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Scopolamine (Primary)
- Indications Motion sickness
- Focus Adverse reactions; Pharmacokinetics
- 30 Nov 2015 New trial record